Emerging Drug Developer: Tengion
While most emerging biotech companies are consumed by the demands of clinical trials, Tengion built a manufacturing center to assist with its mid-stage studies of the neo-bladder. The developer is building new bladders for patients using their own cells to seed replacement organs. The science was advanced by an expert in the field of regenerative medicine and Tengion has its eye on taking this product all the way through to commercialization. With some major league venture backing, they are well on their way. Article